Supplemental material
Open access
1,910
Views
18
CrossRef citations to date
0
Altmetric
Research Paper
(E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity
Le Cong HuanPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; View further author information
, Cao Viet PhuongPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; View further author information
, Le Cong TrucPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; View further author information
, Vo Nguyen ThanhPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; View further author information
, Hai Pham-ThePharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam;
http://orcid.org/0000-0003-4531-7223View further author information
Le-Thi-Thu HuongSchool of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam; View further author information
, Nguyen Thi ThuanPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; View further author information
, Eun Jae ParkCollege of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; View further author information
, A Young JiCollege of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; View further author information
, Jong Soon KangBio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of KoreaView further author information
, Sang-Bae HanCollege of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; Correspondence[email protected]
View further author information
, View further author information
Phuong-Thao TranPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; Correspondence[email protected]
http://orcid.org/0000-0003-4855-2544View further author information
Nguyen-Hai NamPharmaceutical Chemistry, Hanoi University of Pharmacy, Hanoi, Vietnam; Correspondence[email protected]
http://orcid.org/0000-0001-8475-2530View further author information
Pages 465-478
|
Received 14 Sep 2018, Accepted 30 Nov 2018, Published online: 17 Jan 2019
Related Research Data
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Source:
Oxford University Press (OUP)
Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel
Source:
American Association for Cancer Research (AACR)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Source:
Springer Science and Business Media LLC
Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.
Source:
Bentham Science Publishers Ltd.
Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives
Source:
Hindawi Limited
Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma.
Source:
Walter de Gruyter GmbH
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity
Source:
Elsevier BV
Overexpression of caspase-3 in hepatocellular carcinomas.
Source:
Springer Science and Business Media LLC
(E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity
Source:
Taylor & Francis
Synthesis, bioevaluation and docking study of 5-substitutedphenyl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Source:
Informa UK Limited
Elevated procaspase levels in human melanoma.
Source:
Ovid Technologies (Wolters Kluwer Health)
Zinc-Mediated Allosteric Inhibition of Caspase-6
Source:
Elsevier BV
Targeting apoptosis: selected anticancer strategies.
Source:
Springer Science and Business Media LLC
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Source:
Elsevier BV
Procaspase-3 Activation as an Anti-Cancer Strategy: Structure-Activity Relationship of Procaspase-Activating Compound 1 (PAC-1) and its Cellular Co-Localization with Caspase-3
Source:
American Chemical Society (ACS)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.